FDA Approves Invokana canagliflozin to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease

https://medworm.com/624130639/fda-approves-invokana-canagliflozin-to-reduce-the-risk-of-heart-attack-stroke-or-cardiovascular-d/

Comments are closed.